|
Name |
(1r,4r)-1-Methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol
|
Molecular Formula | C10H16O | |
IUPAC Name* |
(1R,4R)-1-methyl-4-prop-1-en-2-ylcyclohex-2-en-1-ol
|
|
SMILES |
CC(=C)[C@@H]1CC[C@@](C=C1)(C)O
|
|
InChI |
InChI=1S/C10H16O/c1-8(2)9-4-6-10(3,11)7-5-9/h4,6,9,11H,1,5,7H2,2-3H3/t9-,10-/m0/s1
|
|
InChIKey |
MKPMHJQMNACGDI-UWVGGRQHSA-N
|
|
Synonyms |
52154-82-2; 7212-40-0; (1r,4r)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol; (1R,4R)-1-methyl-4-prop-1-en-2-ylcyclohex-2-en-1-ol; (+)-trans-p-Mentha-2,8-dien-1-ol; (1R,4R)-p-Mentha-2,8-dien-1-ol; (1R-TRANS) 1-METHYL-4-(1-METHYLETHENYL)-2-CYCLOHEXENE-1-OL; R1AUQ945JN; 7K859030EU; trans-1-Methyl-4-(1-methylethenyl)-2-cyclohexen-1-ol; (1R,4R)-1-Methyl-4-(prop-1-en-2-yl)cyclohex-2-enol; 4-Isopropenyl-1-methyl-cyclohex-2-en-1-ol, (1R*,4R*), rel-; 2-Cyclohexen-1-ol, 1-methyl-4-(1-methylethenyl)-, (1R,4R)-; 2-Cyclohexen-1-ol, 1-methyl-4-(1-methylethenyl)-, (1R,4R)-rel-; 2-Cyclohexen-1-ol, 1-methyl-4-(1-methylethenyl)-, (1R-trans)-; 2-Cyclohexen-1-ol, 1-methyl-4-(1-methylethenyl)-, trans-; (1R,4R)-1-methyl-4-(1-methylethenyl)-2-cyclohexen-1-ol; rel-(1R,4R)-1-Methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol; cis-p-Mentha-2,8-dien-1-ol; UNII-R1AUQ945JN; (Z)-p-Mentha-2,8-dien-1-ol; UNII-7K859030EU; p-Mentha-2,8-dien-1-alpha-ol; EINECS 230-595-4; FEMA No. 4411, trans-(+-)-; (+-)-trans-p-Mentha-2,8-dien-1-ol; 2,8-P-Menthadien-1-ol, trans-(+-)-; cis-2,8-Menthadien-1-ol; SCHEMBL1114908; trans-1-Methyl-4-(1-methylvinyl)cyclohex-2-en-1-ol; cis-p-Mentha-2,8-diene-1-ol; CHEBI:171978; (1R,4R)-1-methyl-4-(1-methylvinyl)-cyclohex-2-ene-1-ol; DTXSID401301235; p-Menth-2,8-dien-1-ol, cis-; p-Mentha-2,8-dien-1-ol, cis-; ZINC5158342; MFCD08460037; AKOS006288261; Mentha-2,8-dien-1-ol, para, cis-; (1R,4R)-p-Mentha-5,8-diene-1-ol; FEMA NO. 4411, TRANS-(+)-; P-MENTHA-2,8-DIEN-1-.ALPHA.-OL; P-MENTHA-2,8-DIEN-1-OL, TRANS-; 2,8-P-MENTHADIEN-1-OL, TRANS-(+)-; P-MENTHA-2,8-DIEN-1-OL, (1R,4R)-; 2,8-P-MENTHADIEN-1-OL, TRANS-(+/-)-; 4-Isopropenyl-1-methyl-2-cyclohexen-1-ol-, cis; P-MENTHA-2,8-DIEN-1-OL, TRANS-(+/-)-; (1R,4R)-4-Isopropenyl-1-methyl-2-cyclohexen-1-ol; 1-Methyl-4-(1-methylethenyl)-2-cyclohexen-1-ol, cis-; 2-Cyclohexen-1-ol, 1-methyl-4-(1-methylethenyl), cis; (1R,4R)-4-ISOPROPENYL-1-METHYL-CYCLOHEX-2-EN-1-OL, (E)-; (+/-)-(1R,4R)-4-ISOPROPENYL-1-METHYL-CYCLOHEX-2-EN-1-OL, (E)-
|
|
CAS | 52154-82-2 | |
PubChem CID | 111274 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 152.23 | ALogp: | 2.4 |
HBD: | 1 | HBA: | 1 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 20.2 | Aromatic Rings: | 1 |
Heavy Atoms: | 11 | QED Weighted: | 0.573 |
Caco-2 Permeability: | -4.301 | MDCK Permeability: | 0.00002380 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.005 |
Human Intestinal Absorption (HIA): | 0.008 | 20% Bioavailability (F20%): | 0.02 |
30% Bioavailability (F30%): | 0.003 |
Blood-Brain-Barrier Penetration (BBB): | 0.942 | Plasma Protein Binding (PPB): | 64.63% |
Volume Distribution (VD): | 1.435 | Fu: | 44.07% |
CYP1A2-inhibitor: | 0.139 | CYP1A2-substrate: | 0.826 |
CYP2C19-inhibitor: | 0.155 | CYP2C19-substrate: | 0.849 |
CYP2C9-inhibitor: | 0.025 | CYP2C9-substrate: | 0.544 |
CYP2D6-inhibitor: | 0.013 | CYP2D6-substrate: | 0.489 |
CYP3A4-inhibitor: | 0.233 | CYP3A4-substrate: | 0.31 |
Clearance (CL): | 4.104 | Half-life (T1/2): | 0.752 |
hERG Blockers: | 0.008 | Human Hepatotoxicity (H-HT): | 0.068 |
Drug-inuced Liver Injury (DILI): | 0.041 | AMES Toxicity: | 0.008 |
Rat Oral Acute Toxicity: | 0.021 | Maximum Recommended Daily Dose: | 0.041 |
Skin Sensitization: | 0.061 | Carcinogencity: | 0.152 |
Eye Corrosion: | 0.927 | Eye Irritation: | 0.989 |
Respiratory Toxicity: | 0.039 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000872 | 0.487 | D07QKN | 0.220 | ||||
ENC002264 | 0.487 | D0P0HT | 0.188 | ||||
ENC002860 | 0.366 | D0H1QY | 0.184 | ||||
ENC001835 | 0.349 | D04GJN | 0.183 | ||||
ENC005066 | 0.276 | D0K7LU | 0.182 | ||||
ENC002124 | 0.276 | D0O1UZ | 0.179 | ||||
ENC002051 | 0.276 | D0F1UL | 0.177 | ||||
ENC005497 | 0.276 | D0IL7L | 0.176 | ||||
ENC003085 | 0.275 | D06AEO | 0.176 | ||||
ENC002073 | 0.273 | D0D1SG | 0.176 |